|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61P 43/00 | (2018.01) |
| C07K 16/28 | (2006.01) | ||
| G01N 33/574 | (2006.01) | ||
| A61K 45/06 | (2013.01) | ||
| A61K 38/00 | (2006.01) | ||
| C07K 16/2827 | (2013.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61K 39/39558 | (2013.01) | ||
| A61K 31/502 | (2006.01) | ||
| A61K 48/00 | (2013.01) | ||
| A61K 31/506 | (2006.01) | ||
| A61K 31/502 | (2013.01) | ||
| A61K 45/06 | (2006.01) | ||
| A61P 35/00 | (2018.01) | ||
| A61K 48/00 | (2006.01) | ||
| A61K 31/506 | (2013.01) | ||
| A61P 9/10 | (2018.01) | ||
| A61P 9/10 | (2006.01) | ||
| A61P 43/00 | (2006.01) | ||
| A61K 39/395 | (2006.01) |
| (11) | Number of the document | 3417294 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17753704.0 |
| Date of filing the European patent application | 2017-02-14 | |
| (97) | Date of publication of the European application | 2018-12-26 |
| (45) | Date of publication and mention of the grant of the patent | 2021-12-01 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2017/017804 |
| Date | 2017-02-14 |
| (87) | Number | WO 2017/142871 |
| Date | 2017-08-24 |
| (30) | Number | Date | Country code |
| 201662295421 P | 2016-02-15 | US |
| (72) |
BARRY, Simon , GB
KENDREW, Jane , GB
HO, Tony , US
WEDGE, Stephen, Robert , GB
IVY,Susan Percy , US
KOHN, Elise , US
LEE, Jung-Min , US
|
| (73) |
Astrazeneca AB ,
151 85 Södertälje,
SE
The United States of America, as Represented By the Secretary, Department of Health and Human Services , Office of Technology Transfer National Institutes of Health 6011 Executive Boulevard Suite 325 MSC 7660, Bethesda, MD 20892-7660, US |
| (54) | METHODS COMPRISING FIXED INTERMITTENT DOSING OF CEDIRANIB |
| METHODS COMPRISING FIXED INTERMITTENT DOSING OF CEDIRANIB |